Publications by Dr Bridget Griffiths - ePrints

Browsing publications by Dr Bridget Griffiths.

Newcastle Authors	Title	Year
Dr Bridget Griffiths Dr Alice Lorenzi Dr Ben Thompson Dr Yaasir Mamoojee	Diagnostic accuracy of morning serum cortisol concentration in confirming recovery of the hypothalamic-pituitary-adrenal axis in patients on chronic glucocorticoid therapy	2024
Dr Bridget Griffiths	Differences in management approaches for lupus nephritis within the UK	2024
Alice Lin Dr Josh Bennett Dr Ewan Hunter Dr Alice Lorenzi Dr Bridget Griffiths et al.	COVID-19 antiviral therapy for non-hospitalised immunosuppressed patients with rheumatic diseases is feasible with positive outcomes	2023
Dr Sadaf Iqbal Professor Jaume Bacardit Dr Bridget Griffiths Professor John Allen	Deep learning classification of systemic sclerosis from multi-site photoplethysmography signals	2023
Dr Shahid Iqbal Professor Jaume Bacardit Dr Bridget Griffiths Professor John Allen	Deep learning classification of systemic sclerosis from multi-site photoplethysmography signals.	2023
Dr Bridget Griffiths	Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope	2023
Dr Bridget Griffiths	The BILAG-2004 index is associated with development of new damage in SLE	2023
Dr Bridget Griffiths	Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally	2022
Dr Rebecca Batten Dr Bridget Griffiths	BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UK	2021
Dr Rebecca Batten Dr Bridget Griffiths	Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus	2021
Dr Bridget Griffiths Anantha Madhavan Deena Harji	A multicentre, prospective, observational cohort study of variation in practice in perioperative analgesia strategies in elective laparoscopic colorectal surgery (the LapCoGesic study)	2020
Peter Coyne Dr Bridget Griffiths Richard Brady	Contemporary smartphone and social media resources for patients with anal cancer: an unmet need	2020
Dr Lesley Kay Dr Bridget Griffiths	Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic	2020
Deena Harji Dr Bridget Griffiths	Laparoscopic versus open colorectal surgery in the acute setting (LaCeS trial): a multicentre randomized feasibility trial	2020
Dr Jessica Tarn Dr Nadia Howard-Tripp Dr Dennis Lendrem Andrew Skelton Dr Katherine James et al.	Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials	2019
Professor John Allen Dr Bridget Griffiths Audrey Macdonald	A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography	2018
Professor Fai Ng Dr Katherine James Dr Bridget Griffiths Dr David Coady Dr Steven Young-Min et al.	Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: Examination of data from the UK Primary Sjögren's Syndrome Registry	2018
Dr Bridget Griffiths Dr James Miller	Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: A 10-year epidemiological study	2018
Professor John Allen Costanzo Di Maria Dr Sam Urwin Emeritus Professor Alan Murray Dr Lesley Ottewell et al.	Novel optical assessments of tissue composition and viability using fluorescence spectroscopy and tissue oxygenation spectrophotometry in patients with systemic sclerosis - a pilot study	2018
Dr Bridget Griffiths	Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register	2018
Shereen Al-Ali Dr Jessica Tarn Dr Dennis Lendrem Dr Bridget Griffiths Professor Fai Ng et al.	Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity	2018
Dr Bridget Griffiths Professor John Isaacs	The EuroMyositis registry: An international collaborative tool to facilitate myositis research	2018
Dr James Locke Dr Bridget Griffiths Professor Fai Ng	A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA	2017
Sheryl Mitchell Dr Katherine James Professor Fai Ng Dr Bridget Griffiths Vicki Hindmarsh et al.	Corrigendum: Eligibility for clinical trials in primary Sjögren's syndrome: Lessons from the UK Primary Sjögren's Syndrome Registry [Rheumatology, 55, (2016) (544-552)] doi:10.1093/rheumatology/kev373	2017
Professor Fai Ng Ariana Miller Dr Steven Young Min Dr David Coady Dr Bridget Griffiths et al.	Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome	2017
Dr Bridget Griffiths Professor John Allen	Quantification of differences between nailfold capillaroscopy images with a scleroderma pattern and normal pattern using measures of geometric and algorithmic complexity	2017
Dr Peter Gallagher Sheryl Mitchell Dr Bridget Griffiths Vicki Hindmarsh Ben Hargreaves et al.	Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren’s Syndrome – Capturing the discrepancy	2017
Dr Bridget Griffiths	The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence guidelines in England and Wales	2017
Dr Nadia Howard-Tripp Dr Jessica Tarn Dr Colin Gillespie Dr Dennis Lendrem Dr Bridget Griffiths et al.	A Cytokine-Mediated Biological Basis for Fatigue in Primary Sjögren’s Syndrome	2016
Dr Bridget Griffiths	BSR and BHPR guideline for the treatment of systemic sclerosis	2016
Dr Bridget Griffiths	Development of Evidence-Based Recommendations for Diagnosis, Assessment and Treatment of Lupus	2016
Sheryl Mitchell Dr Katherine James Professor Fai Ng Dr Bridget Griffiths Vicki Hindmarsh et al.	Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry	2016
Dr Jessica Tarn Andini Natasari Colin Gillespie Sheryl Mitchell Dr Katie Hackett et al.	Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines	2016
Dr Bridget Griffiths	A Paper Patient-Based Flare Study in SLE	2015
Dr Katherine James Shereen Al-Ali Dr Jessica Tarn Dr Simon Cockell Dr Colin Gillespie et al.	A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome	2015
Ben Hargreaves Dr Dennis Lendrem Vicki Hindmarsh Claire Humphrey Sheryl Mitchell et al.	Assignable Causes for Fatigue in Primary Sjögren’s Syndrome: Data from the UK Primary Sjögren’s Syndrome Registry	2015
Dr Dennis Lendrem Sheryl Mitchell Dr Peter McMeekin Dr Katie Hackett Sarah Bowman et al.	Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome?	2015
Dr Prosenjit Dutta Dr Bridget Griffiths Dr Ian Forrest	Efficacy of pulsed cyclophosphamide and methyl-prednisolone therapy in patients with progressive interstitial lung disease	2015
Professor Fai Ng Dr Katherine James Dr Bridget Griffiths Dr James Andrews Dr Vadivelu Saravanan et al.	Eligibility for Clinical Trials in Primary Sjogren's Syndrome: Lessons from the UK Primary Sjogren's Registry	2015
Shereen Al-Ali Dr Simon Cockell Dr Jessica Tarn Dr Katherine James Sarah Bowman et al.	Identification of Whole Blood Gene Expression Signature in Primary Sjogren's Syndrome Associated Lymphoma	2015
Dr Bridget Griffiths	Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register	2015
Dr Jessica Tarn Dr Dennis Lendrem Dr Colin Gillespie Shereen Al-Ali Dr Bridget Griffiths et al.	Patient Sub-Phenotyping in Primary Sjogren's Syndrome	2015
Dr Bridget Griffiths	Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multi-Centre Register	2015
Professor Jaap van Laar Dr Bridget Griffiths	Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial	2014
Sheryl Mitchell Dr Bridget Griffiths Professor Fai Ng	Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results	2014
Dr Dennis Lendrem Sheryl Mitchell Dr Peter McMeekin Dr Bridget Griffiths Professor Fai Ng et al.	Health-related utility values of patients with primary Sjögren's syndrome and its predictors	2014
Shereen Al-Ali Dr Simon Cockell Andrew Skelton Dr Katherine James Dr Jessica Tarn et al.	Identification of Whole Blood Gene Expression Signature in Primary Sjogren's Syndrome Associated Lymphoma	2014
Dr Neil McKay Dr Bridget Griffiths Costanzo Di Maria Stephen Hedley Emeritus Professor Alan Murray et al.	Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study	2014
Dr Bridget Griffiths	Patients with Refractory Systemic Lupus Erythematosus Requiring Biologic Therapy Have Significant Levels of Baseline Co-Morbidities: Results from a National Multi-Centre Register	2014
Dr Bridget Griffiths	Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register	2014
Dr Jessica Tarn Dr Simon Cockell Dr Colin Gillespie Shereen Al-Ali Dr Katherine James et al.	Whole Blood microRNA Signature for Primary Sjogren's Syndrome-Related Lymphoma	2014
Dr Marzena Ciechomska Dr Bridget Griffiths Professor Sophie Hambleton Professor Jaap van Laar	The Role of Serum Factors and Toll-Like Receptor Signaling in the Induction of Profibrotic TIMP-1 by Monocytes in Systemic Sclerosis	2013
Nadine Binai Dr Steven O'Reilly Dr Bridget Griffiths Professor Jaap Van Laar	Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis	2012
Dr Dennis Lendrem Sheryl Mitchell Sarah Bowman Dr Bridget Griffiths Heather Foggo et al.	Evaluating health status of 620 patients with primary sjögren’s syndrome using EQ-5D	2012
Dr Dennis Lendrem Sheryl Mitchell Sarah Bowman Dr David Coady Dr Bridget Griffiths et al.	How good are the eular sjögren’s syndrome disease activity index, and eular sjögren’s syndrome patients reported index in predicting health status in primary sjögren’s syndrome?	2012
Sheryl Mitchell Dr Bridget Griffiths Professor Fai Ng	Potential diagnostic utility of anti-centromere antibody in primary Sjogren's syndrome in the UK	2012
Dr Steven O'Reilly Dr Bridget Griffiths Dr Anja Krippner-Heidenreich Professor Jaap Van Laar	T cell derived IL-6 and IL-13 drive fibroblast fibrosis: Implications for systemic sclerosis	2012
Sheryl Mitchell Dr David Coady Dr Bridget Griffiths Dr Dennis Lendrem Heather Foggo et al.	The clinical relevance of anti-RO52 and anti-RO60 in patients in the united kingdom primary sjögren’s syndrome registry (UKPSSR)	2012
Emerita Professor Julia Newton Sheryl Mitchell Dr Bridget Griffiths Professor Fai Ng	Potentially treatable symptoms in primary Sjogren's Syndrome - Associated fatigue	2011
Professor Fai Ng Dr Bridget Griffiths Professor Marco Carrozzo	United Kingdom Primary Sjogren's Syndrome Registry - a united effort to tackle an orphan rheumatic disease	2011
Dr Thomas Huegle Arie Huigens Dr Lesley Ottewell Dr Bridget Griffiths Professor Jaap Van Laar et al.	The role of fibrocytes in systemic sclerosis [Poster session]	2009
Dr Graham Raftery Dr Bridget Griffiths Dr Lesley Kay Dr David Kane	Chronic viral hepatitis and TNF-alpha blockade	2007
Dr Bridget Griffiths	Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon - A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril	2007
Professor John Allen Elizabeth Kokkinos Emeritus Professor Alan Murray Emeritus Professor Brian Diffey Dr Simon Meggitt et al.	Assessment of skin fluorescence characteristics in systemic sclerosis	2006
Dr Bridget Griffiths Charlotte Gordon	BILAG-2004 index: A reliable tool for assessment of SLE activity	2006
Charlotte Gordon Dr Bridget Griffiths Dr Asad Rahman	Preliminary Rasch analysis of SLEDAI-2000 index: An ordinal scale index with internal construct validity	2006
Dr Bridget Griffiths	Revised British isles lupus assessment group 2004 index - A reliable tool for assessment of systemic lupus erythematosus activity	2006
Professor Namita Kumar Dr Bridget Griffiths Professor John Allen	Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: A potential treatment	2006
Dr Bridget Griffiths Professor John Isaacs	Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study	2005
Dr Bridget Griffiths Professor John Isaacs	Analysis of Fcγ receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B	2005
Dr Bridget Griffiths	Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices	2005
Dr Asad Rahman Dr Bridget Griffiths Charlotte Gordon	BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus	2005
Dr Bridget Griffiths Dr Asad Rahman Charlotte Gordon	BILAG-2004 captures SLE disease activity better than SLEDAI-2000	2005
Dr Bridget Griffiths Charlotte Gordon	BILAG-2004 index: A reliable tool for assessment of SLE activity	2005
Dr Bridget Griffiths Charlotte Gordon	Development and validation of a disease specific quality of life measure for adults with systemic lupus erythematosus, the LupusQoL	2005
Professor John Allen Karen Walker Dr Bridget Griffiths Emeritus Professor Alan Murray	Skin temperature and objective colour measurements in patients with Raynaud’s phenomenon secondary to connective tissue disease	2005
Dr Alice Lorenzi Kathryn Walker Dr Angela Patterson Dr Bridget Griffiths Professor John Isaacs et al.	Thymic function is impaired in patients with a variety of autoimmune diseases	2005
Dr Nitin Kumar Professor John Allen Emeritus Professor Alan Murray Dr Bridget Griffiths	A pilot study assessing the response of single dose sildenafil citrate (Viagra) in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis	2004
Dr Huseyn Sahin Dr Bridget Griffiths	Issues in cross-cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford health assessment questionnaire	2004
Dr Bridget Griffiths Professor Namita Kumar Emeritus Professor Alan Murray	Subject preparation and thermal acclimatization prior to mild cold challenge testing using dynamic thermal imaging	2003
Dr Bridget Griffiths	Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: Influence of reading with or without known sequence	2002
Dr Bridget Griffiths	Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference	2002
Dr Bridget Griffiths	Systemic sclerosis and interstitial lung disease: A pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function	2002
Dr Bridget Griffiths Professor John Isaacs	Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups	2000